about
Crystal structure of a complex between anthrax toxin and its host cell receptorEST-based genome-wide gene inactivation identifies ARAP3 as a host protein affecting cellular susceptibility to anthrax toxinOnset of anthrax toxin pore formationThrough the looking glass, mechanistic insights from enantiomeric human defensinsHuman monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthraxAnthrax lethal toxin-mediated killing of human and murine dendritic cells impairs the adaptive immune responseAcceleration of epithelial cell syndecan-1 shedding by anthrax hemolytic virulence factors.Roles of Anthrax Toxin Receptor 2 in Anthrax Toxin Membrane Insertion and Pore FormationAnthrax prophylaxis: recent advances and future directionsCytoskeleton as an emerging target of anthrax toxinsAnthrax toxin lethal factor domain 3 is highly mobile and responsive to ligand bindingCrystal Structure of the Engineered Neutralizing Antibody M18 Complexed to Domain 4 of the Anthrax Protective AntigenThe Structure of Tumor Endothelial Marker 8 (TEM8) Extracellular Domain and Implications for Its Receptor Function for Recognizing Anthrax ToxinATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infectionProtective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis.Histopathology in a murine model of anthraxIdentification of a surrogate marker for infection in the African green monkey model of inhalation anthraxDetection of anthrax toxin by an ultrasensitive immunoassay using europium nanoparticlesProtective antigen as a correlative marker for anthrax in animal modelsMonoclonal antibody therapies against anthraxSuppressive effects of anthrax lethal toxin on megakaryopoiesisPediatric anthrax clinical managementInhibition of S. aureus alpha-hemolysin and B. anthracis lethal toxin by beta-cyclodextrin derivatives.Search for cyclodextrin-based inhibitors of anthrax toxins: synthesis, structural features, and relative activities.Identification of novel non-hydroxamate anthrax toxin lethal factor inhibitors by topomeric searching, docking and scoring, and in vitro screening.Anthrax lethal toxin paralyzes actin-based motility by blocking Hsp27 phosphorylation.Injection of Staphylococcus aureus EDIN by the Bacillus anthracis protective antigen machinery induces vascular permeability.Effects of spontaneous deamidation on the cytotoxic activity of the Bacillus anthracis protective antigen.Cationic polyamines inhibit anthrax lethal factor proteasePrimary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax.Pathogenesis, virulence, and infective doseSelection and characterization of human antibodies neutralizing Bacillus anthracis toxin.Application of in vivo induced antigen technology (IVIAT) to Bacillus anthracis.Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy.Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthraxQuantitative high-throughput screening identifies inhibitors of anthrax-induced cell deathPerturbation of mouse retinal vascular morphogenesis by anthrax lethal toxin.Comparison of three anthrax toxin neutralization assaysGenetic vaccines for anthrax based on recombinant adeno-associated virus vectorsAnthrax lethal toxin suppresses murine cardiomyocyte contractile function and intracellular Ca2+ handling via a NADPH oxidase-dependent mechanism
P2860
Q24298884-547743D5-3586-49BF-BD8D-007C36D5B60BQ24317584-CE5AD0A9-E072-4D91-86B5-C866BD3EFF70Q24548095-565DC695-66C5-495C-9F89-BB5E7CEC4149Q24652382-D4A453AD-872E-42D9-80C3-5F79F403C838Q24682011-C129ED9F-2967-45CB-BC7C-8A62F15BA66DQ24816298-4C53729A-8BFC-45F5-9D77-F804709CC3FEQ25256591-ADA5F9E5-BFC9-4FCE-84DA-AAA3B0683D95Q26775093-39A9E5E1-04AB-4FB6-B290-F886A008DB8BQ26781366-CB726123-6ADC-4080-BBE0-6791941F5E98Q27005620-06AA22EF-291C-42D4-B637-A458AF50A6BDQ27318044-3435DEA3-F2FC-46DE-A8AB-419F09E9D8D9Q27654632-9B27C0F1-1890-4832-BE8D-E4FC4908AAAAQ27662859-B12CFB8A-C5A5-423B-958C-FE5316113EE5Q28305638-EE39F162-2861-4509-B28F-F5816403DFF7Q28384322-026CC2A9-81CC-48D9-9E93-8B4F507167C3Q28385270-69CCBF60-F415-4B5A-97AC-88CAF348D871Q28386270-0CA1B5AF-432E-4FD2-A5CB-13D655D70687Q28387667-0EF40462-3AFB-4318-ACA8-64E99418DFFEQ28391302-38F90A4D-D45B-466B-A82D-275CC0240CDAQ28393072-D2A4C6D0-7594-4376-92C9-584323E18116Q28396041-D7F46069-0CF0-4BED-9B66-8DE400DAF397Q28397091-7C477F44-668A-4F0C-BAB0-5982419A9B6BQ30441266-8242362B-8952-491B-98BB-E700C3649C39Q30445260-66CEAF7F-0498-496E-B503-E7124A5D7F0DQ30478430-64C3ACDB-74FE-4AC9-95F2-AEDA96DFEFEFQ30479422-A770F5AD-77BD-4058-A694-B77452F6D255Q30489997-888F12A4-14BD-46D1-9B9C-964FF2748939Q33224077-2AD56560-2EB2-43DB-A4A1-17BD158F88EEQ33246181-8ED02126-1097-4CC6-BBC8-3401AB3EB22CQ33286415-8FF18AB9-F49B-4656-958C-BFB7DFC0FA26Q33304216-F8439DA4-8775-47BE-AA86-D418E299197BQ33306246-DAE2F9AB-62C6-458B-B164-F4C148705E75Q33324401-9719F135-429F-451B-9C12-3C25607A4668Q33378594-8235C1E4-B03F-4C92-B307-F9BD2739631EQ33396429-E494716B-FB36-4535-9F38-023EC55E4E03Q33470990-71380436-DFE1-4CE8-8D37-382148E73877Q33502718-23B7060F-B73B-4586-9A1E-76502CD2E100Q33550670-C10B98CB-C561-471D-9337-0E486E282D7EQ33713243-6B2D290B-EA59-4A0B-9A46-B4B5911E7514Q33725456-F16E8E38-3A6E-49F4-9077-1634DAD8D3BC
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The roles of anthrax toxin in pathogenesis.
@ast
The roles of anthrax toxin in pathogenesis.
@en
type
label
The roles of anthrax toxin in pathogenesis.
@ast
The roles of anthrax toxin in pathogenesis.
@en
prefLabel
The roles of anthrax toxin in pathogenesis.
@ast
The roles of anthrax toxin in pathogenesis.
@en
P1476
The roles of anthrax toxin in pathogenesis.
@en
P356
10.1016/J.MIB.2003.12.001
P577
2004-02-01T00:00:00Z